The Japanese Biochemical Society/The Molecular Biology Society of Japan

[1P-1022] BCL2 and JNK signaling pathway as the therapeutic target of imatinib-resistant Ph1-ALL cells, NphA2/STIR and MR87/STIR

〇Chisato Inoue1, Sayaka Sobue1, Yuka Aoyama1, Naoki Mizutani1, Yoshiyuki Kawamoto1, Masatoshi Ichihara1, Motoshi Suzuki2, Yoshinori Nozawa3, Akihiro Abe4, Fumihiko Hayakawa2, Takashi Murate1, Yuji Nishizawa1 (1.Dept. of Biomed. Sci., Chubu Univ. Coll. of Life Health Sci., 2.Dept. of Haematology and Oncology, Nagoya Univ. Grad. Sch. of Med., 3.Dept. of Netrit. Sci., Tokai Gakuin Univ. Coll. of Physic. Ther., 4.Dept. of Haematol. Med. Oncol., Fujita Health Univ. Sch. of Med.)

Ph+ALL、JNK、BCL2、inhibitor

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password